Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma-Reference-Cited by-同舟云学术

Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma

Published:2024-02 Issue: Volume:40 Page:101875
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Thompson Eric M.^ORCID,Kang Kyung-Don^ORCID,Stevenson Kevin,Zhang Hengshan,Gromeier Matthias,Ashley David^ORCID,Brown Michael^ORCID,Friedman Gregory K.

Funder

Department of Defense Peer Reviewed Cancer Research Program

American Brain Tumor Association

Publisher

Elsevier BV

Reference41 articles.

1. Management of pediatric and adult patients with medulloblastoma;Martin;Curr. Treat. Options Oncol.,2014

2. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis;Thompson;Lancet Oncol.,2016

3. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the children's oncology group ACNS0423 study;Jakacki;Neuro. Oncol.,2016

4. Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial;Thompson;Lancet Child Adolesc. Health,2023

5. Recurrent glioblastoma treated with recombinant poliovirus;Desjardins;N. Engl. J. Med.,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictions of Viral-Immunotherapy Glioblastoma Patient Response and Progression using Deep Neural Networks Reveal Novel Biomarkers for Targeted Therapy;SSRN Electronic Journal;2024